Literature DB >> 17872765

Should Canadians be offered systematic prostate cancer screening? No.

Michel Labrecque1, France Légaré, Michel Cauchon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17872765      PMCID： PMC1949195     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  11 in total

1.  Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma.

Authors:  Kishor Mistry; Greg Cable
Journal:  J Am Board Fam Pract       Date:  2003 Mar-Apr

Review 2.  Prostate cancer: 4. Screening.

Authors:  F Meyer; Y Fradet
Journal:  CMAJ       Date:  1998-10-20       Impact factor: 8.262

Review 3.  Prostate cancer: 7. Radiation therapy for localized disease.

Authors:  P Warde; C Catton; M K Gospodarowicz
Journal:  CMAJ       Date:  1998-12-01       Impact factor: 8.262

4.  Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer.

Authors:  J E Montie; D P Wood; J E Pontes; J M Boyett; H S Levin
Journal:  Cancer       Date:  1989-01-15       Impact factor: 6.860

Review 5.  Age and racial distribution of prostatic intraepithelial neoplasia.

Authors:  W A Sakr; D J Grignon; G P Haas; L K Heilbrun; J E Pontes; J D Crissman
Journal:  Eur Urol       Date:  1996       Impact factor: 20.096

6.  Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.

Authors:  Gerald L Andriole; David L Levin; E David Crawford; Edward P Gelmann; Paul F Pinsky; David Chia; Barnett S Kramer; Douglas Reding; Timothy R Church; Robert L Grubb; Grant Izmirlian; Lawrence R Ragard; Jonathan D Clapp; Philip C Prorok; John K Gohagan
Journal:  J Natl Cancer Inst       Date:  2005-03-16       Impact factor: 13.506

Review 7.  Reduction in uptake of PSA tests following decision aids: systematic review of current aids and their evaluations.

Authors:  Rhodri Evans; Adrian Edwards; Joanne Brett; Mike Bradburn; Eila Watson; Joan Austoker; Glyn Elwyn
Journal:  Patient Educ Couns       Date:  2005-07

8.  The evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test.

Authors:  D L Frosch; R M Kaplan; V Felitti
Journal:  J Gen Intern Med       Date:  2001-06       Impact factor: 5.128

9.  Quality of life after radical prostatectomy or watchful waiting.

Authors:  Gunnar Steineck; Fred Helgesen; Jan Adolfsson; Paul W Dickman; Jan-Erik Johansson; Bo Johan Norlén; Lars Holmberg
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245

10.  No reason for immediate repeat sextant biopsy after negative initial sextant biopsy in men with PSA level of 4.0 ng/mL or greater (ERSPC, Rotterdam).

Authors:  M J Roobol; I W van der Cruijsen; F H Schröder
Journal:  Urology       Date:  2004-05       Impact factor: 2.649
View more
  2 in total

1.  Rebuttal: Should Canadians be offered systematic prostate cancer screening? NO.

Authors:  Michel Labrecque; France Légaré; Michel Cauchon
Journal:  Can Fam Physician       Date:  2007-07       Impact factor: 3.275

2.  The sounds of silence.

Authors:  Diane Kelsall
Journal:  Can Fam Physician       Date:  2008-02       Impact factor: 3.275
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.